CRK
Adapter molecule crk
Also known as: CRK_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P46108
- Gene
- CRK
- Ensembl
- ENSG00000167193
- Chromosome
- 17
- Canonical length
- 304 aa
- Protein class
- Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Plasma membrane,Actin filaments,Basal body
- Quaternary structure
- Homodimer
OverviewNCBI Gene
This gene encodes a member of an adapter protein family that binds to several tyrosine-phosphorylated proteins. The product of this gene has several SH2 and SH3 domains (src-homology domains) and is involved in several signaling pathways, recruiting cytoplasmic proteins in the vicinity of tyrosine kinase through SH2-phosphotyrosine interaction. The N-terminal SH2 domain of this protein functions as a positive regulator of transformation whereas the C-terminal SH3 domain functions as a negative regulator of transformation. Two alternative transcripts encoding different isoforms with distinct biological activity have been described. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
304 residues, UniProt reviewed canonical sequence.
>P46108|CRK
1 MAGNFDSEER SSWYWGRLSR QEAVALLQGQ RHGVFLVRDS STSPGDYVLS VSENSRVSHY
61 IINSSGPRPP VPPSPAQPPP GVSPSRLRIG DQEFDSLPAL LEFYKIHYLD TTTLIEPVSR
121 SRQGSGVILR QEEAEYVRAL FDFNGNDEED LPFKKGDILR IRDKPEEQWW NAEDSEGKRG
181 MIPVPYVEKY RPASASVSAL IGGNQEGSHP QPLGGPEPGP YAQPSVNTPL PNLQNGPIYA
241 RVIQKRVPNA YDKTALALEV GELVKVTKIN VSGQWEGECN GKRGHFPFTH VRLLDQQNPD
301 EDFSLocalizationUniProt · AlphaFold · HPA
Whether an antibody against CRK can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Cell surface
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.42
- Highest tissue expression
- 47 nTPM
Expression across tissuesHPA
Tissue
- liver: 47 nTPM
- adipose tissue: 45 nTPM
- placenta: 40 nTPM
- tongue: 35 nTPM
- blood vessel: 35 nTPM
- thyroid gland: 34 nTPM
Single-cell type
- choroid plexus epithelial cells: 105 nCPM
- microglia: 71 nCPM
- proximal tubule cells: 69 nCPM
- papillary tip epithelial cells: 67 nCPM
- renal collecting duct intercalated cells: 67 nCPM
- renal connecting tubule cells: 62 nCPM
Immune cell
- neutrophil: 14 nTPM
- basophil: 6.2 nTPM
- eosinophil: 5.3 nTPM
- naive B-cell: 5.2 nTPM
- non-classical monocyte: 4.4 nTPM
- myeloid DC: 4.3 nTPM
Brain region
- thalamus: 48 nTPM
- spinal cord: 46 nTPM
- midbrain: 45 nTPM
- medulla oblongata: 45 nTPM
- pons: 44 nTPM
- white matter: 43 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about CRK.
Disease | ImmuneIEDB
Conditions an epitope on CRK was assayed in.
- brain glioma T cell
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.33
- gnomAD pLI
- 0.96
- gnomAD missense Z
- 2.37
- DepMap mean gene effect
- -0.17
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- actin cytoskeleton organization
- cell chemotaxis
- cell migration
- cell population proliferation
- cellular response to endothelin
- cellular response to insulin-like growth factor stimulus
- cellular response to nerve growth factor stimulus
- cellular response to nitric oxide
- cellular response to transforming growth factor beta stimulus
- cerebellar neuron development
- cerebral cortex development
- dendrite development
- enzyme-linked receptor protein signaling pathway
- ephrin receptor signaling pathway
- establishment of cell polarity
- helper T cell diapedesis
- hippocampus development
- lipid metabolic process
- negative regulation of cell motility
- negative regulation of natural killer cell mediated cytotoxicity
- negative regulation of wound healing
- neuron migration
- positive regulation of cell growth
- positive regulation of JNK cascade
- positive regulation of Rac protein signal transduction
- positive regulation of skeletal muscle acetylcholine-gated channel clustering
- positive regulation of smooth muscle cell migration
- positive regulation of substrate adhesion-dependent cell spreading
- postsynaptic specialization assembly
- protein localization to membrane
- Rac protein signal transduction
- reelin-mediated signaling pathway
- regulation of actin cytoskeleton organization
- regulation of cell adhesion mediated by integrin
- regulation of cell shape
- regulation of dendrite development
- regulation of GTPase activity
- regulation of intracellular signal transduction
- regulation of signal transduction
- regulation of T cell migration
- regulation of transcription by RNA polymerase II
- response to cholecystokinin
- response to hydrogen peroxide
- response to peptide
- response to yeast
- response to hepatocyte growth factor
Molecular functions
- cytoskeletal protein binding
- ephrin receptor binding
- insulin-like growth factor receptor binding
- kinase binding
- phosphotyrosine residue binding
- protein phosphorylated amino acid binding
- protein tyrosine kinase binding
- receptor tyrosine kinase binding
- scaffold protein binding
- SH2 domain binding
- SH3 domain binding
- signaling adaptor activity
- signaling receptor complex adaptor activity
- ubiquitin protein ligase binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of CRK in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads CRK as an antibody target. Whether an autoantibody or antibody against CRK could matter depends on whether native CRK is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
CRK is annotated at the cell surface, where native CRK is exposed to circulating antibodies and is a prime autoantibody target that could block, deplete, or overstimulate it.
Annotation status
The present source text does not explicitly label CRK as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...